Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,460.00    44.00 (3.11%)
Bid:
1,453.00
Ask:
1,454.00
Spread: 1.00 (0.069%)
Market Cap: £3.10b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Director Declaration

29 Jul 2024 16:08

RNS Number : 2662Y
Hikma Pharmaceuticals Plc
29 July 2024
 

Hikma Pharmaceuticals PLC

Director Declaration

LONDON, 29 July 2024: Pursuant to Listing Rule 9.6.14, Hikma Pharmaceuticals PLC confirms that Victoria Hull, Senior Independent Non-Executive Director, has been appointed as a Non-Executive Director of IMI plc with effect from 1 August 2024.

- ENDS -

 

Enquiries:

 

Hikma Pharmaceuticals PLC

 

Helen Middlemist

Group Company Secretary

+44 20 7399 2760

 

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)

(LEI: 549300BNS685UXH4JI75)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNRLMATMTMTBRI
Date   Source Headline
29th Apr 20227:15 amRNSTrading Statement
28th Apr 20226:05 pmRNSTransaction in Own Shares
27th Apr 20226:17 pmRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTransaction in Own Shares
25th Apr 20226:04 pmRNSTransaction in Own Shares
25th Apr 20223:42 pmRNSResult of AGM
25th Apr 20227:00 amRNSNotice of GM
22nd Apr 20226:15 pmRNSTransaction in Own Shares
21st Apr 20226:06 pmRNSTransaction in Own Shares
21st Apr 20222:15 pmRNSAcquisition
20th Apr 20225:59 pmRNSTransaction in Own Shares
20th Apr 20227:00 amRNSFTC preliminary approval for Custopharm
19th Apr 20225:49 pmRNSTransaction in Own Shares
14th Apr 20225:35 pmRNSTransaction in Own Shares
13th Apr 20225:19 pmRNSTransaction in Own Shares
12th Apr 20225:55 pmRNSTransaction in Own Shares
12th Apr 20225:49 pmRNSDirector/PDMR Shareholding
11th Apr 20226:09 pmRNSTransaction in Own Shares
11th Apr 20227:00 amRNSShare Buyback Programme
8th Apr 20225:16 pmRNSTransaction in Own Shares
7th Apr 20225:53 pmRNSTransaction in Own Shares
5th Apr 20225:59 pmRNSTransaction in Own Shares
4th Apr 20226:09 pmRNSTransaction in Own Shares
1st Apr 20226:13 pmRNSTransaction in Own Shares
1st Apr 20225:46 pmRNSBlock listing Interim Review
31st Mar 20226:09 pmRNSTransaction in Own Shares
30th Mar 20225:57 pmRNSTransaction in Own Shares
30th Mar 202212:54 pmRNSTransaction in Own Shares
28th Mar 20226:09 pmRNSTransaction in Own Shares
25th Mar 20225:55 pmRNSTransaction in Own Shares
24th Mar 20226:03 pmRNSTransaction in Own Shares
23rd Mar 20225:08 pmRNSTransaction in Own Shares
22nd Mar 20226:03 pmRNSTransaction in Own Shares
21st Mar 20225:58 pmRNSTransaction in Own Shares
18th Mar 20226:32 pmRNSTransaction in Own Shares
17th Mar 20226:03 pmRNSTransaction in Own Shares
17th Mar 202210:00 amRNSAnnual Financial Report
16th Mar 20225:48 pmRNSTransaction in Own Shares
15th Mar 20225:51 pmRNSTransaction in Own Shares
15th Mar 202210:58 amRNSDirector/PDMR Shareholding
14th Mar 20226:23 pmRNSTransaction in Own Shares
11th Mar 20226:11 pmRNSTransaction in Own Shares
10th Mar 20225:48 pmRNSTransaction in Own Shares
9th Mar 20225:53 pmRNSTransaction in Own Shares
8th Mar 20225:21 pmRNSTransaction in Own Shares
8th Mar 202210:21 amRNSHolding(s) in Company
7th Mar 20225:12 pmRNSTransaction in Own Shares
7th Mar 20221:36 pmRNSDirector/PDMR Shareholding
4th Mar 20226:20 pmRNSTransaction in Own Shares
3rd Mar 20225:44 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.